The extracellular chaperone clusterin potently inhibits human lysozyme amyloid formation by interacting with prefibrillar species.
We have studied the effects of the extracellular molecular chaperone, clusterin, on the in vitro aggregation of mutational variants of human lysozyme, including one associated with familial amyloid disease. The aggregation of the amyloidogenic variant I56T is inhibited significantly at clusterin to...
Hlavní autoři: | Kumita, JR, Poon, S, Caddy, G, Hagan, C, Dumoulin, M, Yerbury, J, Stewart, E, Robinson, C, Wilson, MR, Dobson, C |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
2007
|
Podobné jednotky
-
Rationalising lysozyme amyloidosis: insights from the structure and solution dynamics of T70N lysozyme.
Autor: Johnson, R, a další
Vydáno: (2005) -
The extracellular chaperone Clusterin enhances Tau aggregate seeding in a cellular model
Autor: Patricia Yuste-Checa, a další
Vydáno: (2021-08-01) -
The significance of the location of mutations for the native-state dynamics of human lysozyme
Autor: Ahn, M, a další
Vydáno: (2016) -
The Extracellular Molecular Chaperone Clusterin Inhibits Amyloid Fibril Formation and Suppresses Cytotoxicity Associated with Semen-Derived Enhancer of Virus Infection (SEVI)
Autor: Abigail K. Elias, a další
Vydáno: (2022-10-01) -
Expression and purification of chaperone-active recombinant clusterin.
Autor: Rebecca A Dabbs, a další
Vydáno: (2014-01-01)